Integrated Analysis Identified TGFBI as a Biomarker of Disease Severity and Prognosis Correlated with Immune Infiltrates in Patients with Sepsis

CONCLUSION: TGFBI warrants additional exploration as a promising biomarker for assessing illness severity and prognosis in patients with sepsis, considering its significant association with immunological and inflammatory responses in this condition.PMID:38645878 | PMC:PMC11027929 | DOI:10.2147/JIR.S456132
Source: Cell Research - Category: Cytology Authors: Source Type: research